Skip to main content
. 2020 Apr 30;122(12):1760–1768. doi: 10.1038/s41416-020-0846-2

Table 2.

Summary of Grade > 3 CTCAEs occurring in at least 5% patients.

CON (n = 74) SEQ (n = 68)
Grade 3, Grade 4, Grade 5, Grade 3, Grade 4, Grade 5,
n % n % n % n % n % n %
No. of patients experiencing worst-grade AEs 44 59 12 16 5 7 29 43 27 40 10 15
Fatigue 15 20 0 0 0 0 16 24 0 0 0 0
Neutrophil count decreased 20 27 4 5 0 0 19 28 21 31 0 0
Nausea 2 3 0 0 0 0 6 9 0 0 0 0
Diarrhoea 4 5 0 0 0 0 6 9 0 0 0 0
Anaemia 4 5 0 0 0 0 8 12 0 0 0 0
Vomiting 8 11 0 0 0 0 5 7 0 0 0 0
Abdominal pain 4 5 0 0 0 0 3 4 0 0 0 0
Platelet count decreased 7 9 1 1 0 0 2 3 1 1 0 0
White blood cell decreased 1 1 2 3 0 0 4 6 2 3 0 0
Lung infection 4 5 0 0 3 4 4 6 0 0 2 3
Febrile neutropaenia 6 8 2 3 1 1 7 10 3 4 1 1
GGT increased 5 7 2 3 0 0 2 3 1 1 0 0
Alanine aminotransferase increased 2 3 0 0 0 0 5 7 1 1 0 0
Thromboembolic event 2 3 0 0 0 0 4 6 0 0 1 1
Bilirubin increased 1 1 0 0 0 0 8 12 0 0 0 0
Sepsis 0 0 5 7 0 0 0 0 4 6 2 3
Dehydration 3 4 0 0 0 0 5 7 0 0 0 0
Hypotension 3 4 0 0 0 0 4 6 0 0 0 0
Other grade 5 AEs 1 gallbladder obstruction 1 pneumonitis, 1 colitis, 1 hypoxia and 1 cholangitis